Guangzhou Baiyunshan Pharmaceutical Holdings (SHA:600332) subsidiary Guangzhou Baiyunshan Mingxing Pharmaceutical received supplementary drug approval from China's National Medical Products Administration for its norepinephrine bitartrate injection.
The drug approval covers drug prescription and manufacturing processes, registration, packaging materials, and revision of drug instructions.
The drug is indicated for low blood pressure control.
Qantas Airways' (ASX:QAN) Jetstar unit will operate a new direct route between Melbourne in Victoria and Colombo in Sri Lanka, according to a Tuesday statement.The flights run three times a week, on Tuesdays, Thursdays, and Saturdays.Qantas Airways' shares rose past 1% in recent trading on Tuesday.
Shenzhen Longsys Electronics (SHE:301308) passed its listing hearing with the Hong Kong bourse, paving the way for its proposed secondary offering in the city to proceed, according to a Monday after-hours filing with the Shenzhen Stock Exchange.The semiconductor memory product company plans to use proceeds from the offering to enhance its research and development capabilities, grow its packaging and testing facility in Brazil, boost sales and marketing, fund strategic investments, and for working capital, according to its post-hearing information pack.
Hansen Technologies (ASX:HSN) partnered with InvoiceCloud to integrate its Hansen CIS software products with InvoiceCloud's digital payments platform, according to a Tuesday Australian bourse filing.The firms plan to support bill generation, presentment, payment, and reconciliation for utilities, energy retailers, and local governments across North America.Its shares rose 2% in recent trade on Tuesday.